Hybrid quantum-classical graph neural networks for tumor classification in digital pathology
Authors:
Anupama Ray,
Dhiraj Madan,
Srushti Patil,
Maria Anna Rapsomaniki,
Pushpak Pati
Abstract:
Advances in classical machine learning and single-cell technologies have paved the way to understand interactions between disease cells and tumor microenvironments to accelerate therapeutic discovery. However, challenges in these machine learning methods and NP-hard problems in spatial Biology create an opportunity for quantum computing algorithms. We create a hybrid quantum-classical graph neural…
▽ More
Advances in classical machine learning and single-cell technologies have paved the way to understand interactions between disease cells and tumor microenvironments to accelerate therapeutic discovery. However, challenges in these machine learning methods and NP-hard problems in spatial Biology create an opportunity for quantum computing algorithms. We create a hybrid quantum-classical graph neural network (GNN) that combines GNN with a Variational Quantum Classifier (VQC) for classifying binary sub-tasks in breast cancer subty**. We explore two variants of the same, the first with fixed pretrained GNN parameters and the second with end-to-end training of GNN+VQC. The results demonstrate that the hybrid quantum neural network (QNN) is at par with the state-of-the-art classical graph neural networks (GNN) in terms of weighted precision, recall and F1-score. We also show that by means of amplitude encoding, we can compress information in logarithmic number of qubits and attain better performance than using classical compression (which leads to information loss while kee** the number of qubits required constant in both regimes). Finally, we show that end-to-end training enables to improve over fixed GNN parameters and also slightly improves over vanilla GNN with same number of dimensions.
△ Less
Submitted 17 October, 2023;
originally announced October 2023.
Towards quantum-enabled cell-centric therapeutics
Authors:
Saugata Basu,
Jannis Born,
Aritra Bose,
Sara Capponi,
Dimitra Chalkia,
Timothy A Chan,
Hakan Doga,
Frederik F. Flother,
Gad Getz,
Mark Goldsmith,
Tanvi Gujarati,
Aldo Guzman-Saenz,
Dimitrios Iliopoulos,
Gavin O. Jones,
Stefan Knecht,
Dhiraj Madan,
Sabrina Maniscalco,
Nicola Mariella,
Joseph A. Morrone,
Khadijeh Najafi,
Pushpak Pati,
Daniel Platt,
Maria Anna Rapsomaniki,
Anupama Ray,
Kahn Rhrissorrakrai
, et al. (8 additional authors not shown)
Abstract:
In recent years, there has been tremendous progress in the development of quantum computing hardware, algorithms and services leading to the expectation that in the near future quantum computers will be capable of performing simulations for natural science applications, operations research, and machine learning at scales mostly inaccessible to classical computers. Whereas the impact of quantum com…
▽ More
In recent years, there has been tremendous progress in the development of quantum computing hardware, algorithms and services leading to the expectation that in the near future quantum computers will be capable of performing simulations for natural science applications, operations research, and machine learning at scales mostly inaccessible to classical computers. Whereas the impact of quantum computing has already started to be recognized in fields such as cryptanalysis, natural science simulations, and optimization among others, very little is known about the full potential of quantum computing simulations and machine learning in the realm of healthcare and life science (HCLS). Herein, we discuss the transformational changes we expect from the use of quantum computation for HCLS research, more specifically in the field of cell-centric therapeutics. Moreover, we identify and elaborate open problems in cell engineering, tissue modeling, perturbation modeling, and bio-topology while discussing candidate quantum algorithms for research on these topics and their potential advantages over classical computational approaches.
△ Less
Submitted 1 August, 2023; v1 submitted 11 July, 2023;
originally announced July 2023.